3 Growth Stocks You Can Buy Right Now Without Any Hesitation
https://www.fool.com/investing/2024/06/15/3-growth-stocks-you-can-buy-right-now-without-any/?source=iedfolrf0000001
Jun 15, 2024 - Want peace of mind about your investments? Consider these great stocks.
0
Novo Nordisk (NVO) Advances While Market Declines: Some Information for Investors
https://www.zacks.com/stock/news/2288728/novo-nordisk-nvo-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2288728
Jun 14, 2024 - Novo Nordisk (NVO) closed the most recent trading day at $142.50, moving +0.01% from the previous trading session.
0
Weight Loss Drugs: Are They Really Magic?
https://www.fool.com/investing/2024/06/13/weight-loss-drugs-are-they-really-magic/?source=iedfolrf0000001
Jun 13, 2024 - Talking about weight and weight loss with Johann Hari, an Ozempic user and the author of "Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs."
0
Structure Therapeutics (GPCR) Rallying on Obesity Drug Data
https://www.zacks.com/stock/news/2286691/structure-therapeutics-gpcr-rallying-on-obesity-drug-data?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2286691
Jun 11, 2024 - Structure Therapeutics (GPCR) stock sees an upside on positive top-line data from a phase IIa obesity study as well as a capsule-to-tablet PK study on its obesity candidate, GSBR-1290.
0
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2286038/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2286038
Jun 10, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Macy's and Five Below have been highlighted as Zacks Bull and Bear of the Day
https://www.zacks.com/stock/news/2285831/macy-s-and-five-below-have-been-highlighted-as-zacks-bull-and-bear-of-the-day?cid=CS-ZC-FT-press_releases-2285831
Jun 10, 2024 - Macy's and Five Below have been highlighted as Zacks Bull and Bear of the Day
0
Here's Why Demand for Ozempic and Wegovy Could Soar Even Higher
https://www.fool.com/investing/2024/06/08/heres-why-demand-for-ozempic-and-wegovy-could-soar/?source=iedfolrf0000001
Jun 08, 2024 - Novo Nordisk's stock may not look all that expensive when you're focusing on the long-term potential.
0
Top Analyst Reports for Novo Nordisk, TotalEnergies & U.S. Bancorp
https://www.zacks.com/commentary/2285106/top-analyst-reports-for-novo-nordisk-totalenergies-u-s-bancorp?cid=CS-ZC-FT-research_daily-2285106
Jun 07, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), TotalEnergies SE (TTE) and U.S. Bancorp (USB), as well as a micro-cap stock Flanigan's Enterprises, Inc. (BDL).
0
Ozempic Just Got Even More Bullish For Novo Nordisk Stock, Yet Again
https://www.fool.com/investing/2024/06/06/ozempic-just-got-more-bullish-for-novo-nordisk/?source=iedfolrf0000001
Jun 06, 2024 - The market for treating chronic kidney disease is nearly within reach.
0
Here Are 3 More Reasons to Be Bullish on Ozempic and Novo Nordisk Stock
https://www.fool.com/investing/2024/06/04/here-are-3-more-reasons-to-be-bullish-on-ozempic/?source=iedfolrf0000001
Jun 04, 2024 - There's new evidence suggesting the drug will find another large market.
0